CTI BioPharma to Present at the JMP Securities Hematology & Oncology Summit on Monday, December 6

Rhea-AI Summary

CTI BioPharma Corp. (NASDAQ: CTIC) will present a corporate overview on December 6, 2021, at 3:40 p.m. ET during the JMP Securities Hematology & Oncology Summit, held virtually. The presentation will be available for live streaming and replay on the company’s website. CTI BioPharma focuses on developing targeted therapies for blood-related cancers, particularly with their candidate pacritinib, currently in late-stage development. The company is headquartered in Seattle, Washington.

SEATTLE, Dec. 2, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the JMP Securities Hematology & Oncology Summit at 3:40 p.m. ET. The conference will be held in a virtual meeting format.

Presentation details: 
Event: JMP Securities Hematology & Oncology Summit  
Date: Monday, December 6, 2021 
Time: 3:40 p.m. ET

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.

About CTI BioPharma Corp. 
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on developing and commercializing pacritinib, our product candidate currently in active late-stage development. We are headquartered in Seattle, Washington.

CTI BioPharma Investor Contacts: 
Argot Partners 
+212-600-1902 
cti@argotpartners.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-jmp-securities-hematology--oncology-summit-on-monday-december-6-301436710.html

SOURCE CTI BioPharma Corp.

FAQ

When will CTI BioPharma present at the JMP Securities Hematology & Oncology Summit?

CTI BioPharma will present on December 6, 2021, at 3:40 p.m. ET.

How can I watch CTI BioPharma's presentation at the JMP Securities Summit?

The presentation will be webcast live and available for replay on CTI BioPharma's website.

What is the main focus of CTI BioPharma?

CTI BioPharma focuses on developing novel targeted therapies for blood-related cancers.

What product candidate is CTI BioPharma currently developing?

CTI BioPharma is actively developing pacritinib, a treatment for blood-related cancers.

Where is CTI BioPharma headquartered?

CTI BioPharma is headquartered in Seattle, Washington.